AdeleHRikePharmD

PubMed

• Use of HCV Ab+/NAT- Donors in HCV Naïve Renal Transplant Recipients to Expand the Kidney Donor Pool.
  Dao, A.,Cuffy, M.,Kaiser, T. E.,Loethen, A.,Cafardi, J.,Luckett, K.,Rike, A. H.,Cardi, M.,Alloway, R.,Govil, A.,Diwan, T.,Sherman, K. E.,Shah, S.,Woodle, E. S.> ;Clin Transplant. 2019 May 20
• A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
  Walker, J. K.,Alloway, R. R.,Roy-Chaudhury, P.,Mogilishetty, G.,Cardi, M. A.,Weimert, N. A.,Rike, A. H.,First, M. R.,Woodle, E. S.> ;Transplantation. 2009 Feb 10
• Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.
  Everly, M. J.,Everly, J. J.,Susskind, B.,Brailey, P.,Arend, L. J.,Alloway, R. R.,Roy-Chaudhury, P.,Govil, A.,Mogilishetty, G.,Rike, A. H.,Cardi, M.,Wadih, G.,Tevar, A....> ;Transplantation. 2008 Dec 24
• 53 citations
  Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and chronic steroids.
  A. H. Rike, G. Mogilishetty, Rita R. Alloway, Paul Succop, Prabir Roy-Chaudhury, Michael Cardi, Tiffany E. Kaiser, Mark Thomas, E. Steve Woodle> ;Clinical Transplantation. 2007 Nov 8
• Join now to see all